Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $36
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper (KDP) and raises the price target from $32 to $36.
April 12, 2024 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper and raises the price target from $32 to $36.
The increase in price target by Barclays reflects a positive outlook on Keurig Dr Pepper's stock, suggesting potential upside. This analyst endorsement could lead to increased investor confidence and a short-term rise in KDP's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100